151 related articles for article (PubMed ID: 37597693)
1. Anaphylaxis and systemic mastocytosis controlled with KIT inhibitors in a patient with metastatic lung adenocarcinoma.
Hernandez CL; Lynch DM; Golash AJ; Marquis K; Besz KM; Oxnard G; Rotow J; DeAngelo DJ; Castells M
Ann Allergy Asthma Immunol; 2023 Nov; 131(5):668-670. PubMed ID: 37597693
[No Abstract] [Full Text] [Related]
2. Systemic mastocytosis with an associated hematologic neoplasm complicated by recurrent anaphylaxis: Prompt resolution of anaphylaxis with the addition of avapritinib.
Kudlaty E; Perez M; Stein BL; Bochner BS; Kuang FL
J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2534-2536. PubMed ID: 33677080
[No Abstract] [Full Text] [Related]
3. [IgE mediated anaphylaxis in a patient with systemic mastocytosis].
Escande H; Bennani I; Bulai Livideanu C; Uthurriague C; Paul C; Nougué J
Ann Dermatol Venereol; 2013 Oct; 140(10):641-4. PubMed ID: 24090896
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive dysfunction and anaphylaxis in pediatric maculopapular cutaneous mastocytosis.
Gurnee EA; Phung TL; Guo E; Fong A; Tollefson M; Nguyen H; Brandling-Bennett HA; Moriarty N; Paller AS; Huynh T; Lawley LP
J Allergy Clin Immunol Pract; 2020 Jan; 8(1):409-410. PubMed ID: 31279039
[No Abstract] [Full Text] [Related]
5. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.
Alvarez-Twose I; Zanotti R; González-de-Olano D; Bonadonna P; Vega A; Matito A; Sánchez-Muñoz L; Morgado JM; Perbellini O; García-Montero A; De Matteis G; Teodósio C; Rossini M; Jara-Acevedo M; Schena D; Mayado A; Zamò A; Mollejo M; Sánchez-López P; Cabañes N; Orfao A; Escribano L; ;
J Allergy Clin Immunol; 2014 Feb; 133(2):520-8. PubMed ID: 23921094
[TBL] [Abstract][Full Text] [Related]
6. Mastocytosis.
Abid A; Malone MA; Curci K
Prim Care; 2016 Sep; 43(3):505-18. PubMed ID: 27545739
[TBL] [Abstract][Full Text] [Related]
7. Mast Cell Activation Syndromes: Comparison Between Two Scoring Models to Predict for Mast Cell Clonality.
Rama TA; Torrado I; Henriques AF; Sánchez-Muñoz L; Jara-Acevedo M; Navarro-Navarro P; Caldas C; Mayado A; Muñoz-González J; García-Montero A; Mollejo M; Redondo E; Garbán A; Moreira A; Órfão A; Álvarez-Twose I
J Allergy Clin Immunol Pract; 2023 Mar; 11(3):908-919.e4. PubMed ID: 36535520
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic and diagnostic relevance of KIT in primary mast cell activation disorders.
Muñoz-González JI; García-Montero AC; Orfao A; Álvarez-Twose I
Ann Allergy Asthma Immunol; 2021 Oct; 127(4):427-434. PubMed ID: 34298172
[TBL] [Abstract][Full Text] [Related]
9. Hymenoptera Allergy and Mast Cell Activation Syndromes.
Bonadonna P; Bonifacio M; Lombardo C; Zanotti R
Curr Allergy Asthma Rep; 2016 Jan; 16(1):5. PubMed ID: 26714690
[TBL] [Abstract][Full Text] [Related]
10. Effector cells of anaphylaxis: mast cells and basophils.
Schwartz LB
Novartis Found Symp; 2004; 257():65-74; discussion 74-9, 98-100, 276-85. PubMed ID: 15025392
[TBL] [Abstract][Full Text] [Related]
11. Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis.
Gulen T
Immunol Allergy Clin North Am; 2023 Nov; 43(4):681-698. PubMed ID: 37758406
[TBL] [Abstract][Full Text] [Related]
12. IgE-mediated anaphylaxis to methylprednisolone succinate in a patient with indolent systemic mastocytosis.
Van Mieghem E; Beyens M; Van Gasse AL; Verlinden A; Ebo DG; Sabato V
Allergol Int; 2022 Oct; 71(4):552-554. PubMed ID: 35817697
[No Abstract] [Full Text] [Related]
13. Proposed European Competence Network on Mastocytosis-American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis.
Gotlib J; Schwaab J; Shomali W; George TI; Radia DH; Castells M; Carter MC; Hartmann K; Álvarez-Twose I; Brockow K; Bonadonna P; Hermine O; Niedoszytko M; Hoermann G; Sperr WR; Elberink HO; Siebenhaar F; Butterfield JH; Ustun C; Zanotti R; Triggiani M; Schwartz LB; Lyons JJ; Orfao A; Sotlar K; Horny HP; Arock M; Metcalfe DD; Akin C; Lübke J; Valent P; Reiter A
J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2025-2038.e1. PubMed ID: 35724948
[TBL] [Abstract][Full Text] [Related]
14. [Vulvar oedema revealing systemic mastocytosis].
Deveza E; Locatelli F; Girardin M; Valmary-Degano S; Daguindau E; Aubin F; Humbert P; Pelletier F
Ann Dermatol Venereol; 2015 Nov; 142(11):685-9. PubMed ID: 26003033
[TBL] [Abstract][Full Text] [Related]
15. Fate of two mast cell tryptases in V3 mastocytosis and normal BALB/c mice undergoing passive systemic anaphylaxis: prolonged retention of exocytosed mMCP-6 in connective tissues, and rapid accumulation of enzymatically active mMCP-7 in the blood.
Ghildyal N; Friend DS; Stevens RL; Austen KF; Huang C; Penrose JF; Sali A; Gurish MF
J Exp Med; 1996 Sep; 184(3):1061-73. PubMed ID: 9064323
[TBL] [Abstract][Full Text] [Related]
16. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of Primary Mast Cell Disorders in Anaphylaxis: Value of KIT D816V in Peripheral Blood.
De Puysseleyr LP; Ebo DG; Elst J; Faber MA; Poorten MV; Van Gasse AL; Bridts CH; Mertens C; Van Houdt M; Hagendorens MM; Verlinden A; Vermeulen K; Maes MB; Berneman ZN; Sabato V
J Allergy Clin Immunol Pract; 2021 Aug; 9(8):3176-3187.e3. PubMed ID: 33975032
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine kinase inhibitors for the treatment of indolent systemic mastocytosis: Are we there yet?
Akin C; Arock M; Valent P
J Allergy Clin Immunol; 2022 Jun; 149(6):1912-1918. PubMed ID: 35487307
[TBL] [Abstract][Full Text] [Related]
19. Anaphylaxis and mastocytosis.
Russell WJ
Anaesth Intensive Care; 2009 Nov; 37(6):1037; author reply 1037-8. PubMed ID: 20014616
[No Abstract] [Full Text] [Related]
20. Diagnostic value of tryptase in anaphylaxis and mastocytosis.
Schwartz LB
Immunol Allergy Clin North Am; 2006 Aug; 26(3):451-63. PubMed ID: 16931288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
